Viewing Study NCT07108504


Ignite Creation Date: 2025-12-24 @ 7:59 PM
Ignite Modification Date: 2025-12-29 @ 7:51 PM
Study NCT ID: NCT07108504
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-07
First Post: 2025-07-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Sponsor: Shanghai Zhongshan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module